Effect of Prenatal Repair of Myelomeningocele on Urological Outcomes at School Age

Authors:
  • FMFor the Eunice Kennedy Shriver Nichd, Moms Trial Group, Bethesda, MD
    For the Eunice Kennedy Shriver Nichd, Moms Trial Group, Bethesda, MD

Abstract
Purpose:To investigate longer-term urological outcomes in patients enrolled in the Management of Myelomeningocele Study (MOMS).Materials and Methods:Women who participated in the original trial were asked for consent to their child being followed-up at 6 years or older in a single comprehensive study visit to a MOMS center. Participating children underwent urologic and radiologic procedures to provide objective evidence of current bladder functioning. Primary urologic outcome was defined as any: need for CIC, vesicostomy, urethral dilatation or augmentation cystoplasty.Results:156 children were analyzed, mean age 7.4 years. 62% versus 87% in the prenatal and postnatal surgery groups respectively were placed on CIC (RR 0.71, 95% CI 0.58-0.86 p<0.001). Voiding status was significantly different between the groups (p= p<0.001); 24% in the prenatal group versus 4% in the postnatal group (RR 5.8, 95% CI 1.8-18.7) were reported to be voiding volitionally. Augmentation cystoplasty, vesicostomy, and ureth...